ImCheck to Present Data from the Ongoing Phase I/IIa EVICTION Trial

Details of the oral presentation are:
Abstract Title: “Coordinated Activation of Antitumor Responses of g9d2 and CD8 T Cells by Targeting BTN3A with ICT01 in Patients with Solid Tumors: EVICTION Trial”
Session Title: Proffered Paper session - Investigational immunotherapy
Presentation Number: 958O
Presenter: Aurélien Marabelle, MD, PhD, Immuno-Oncologist at Gustave Roussy, Villejuif, France and Lead Investigator for EVICTION
Date: Friday Sept. 17, 2021
Lecture Time: 13:50 - 14:00 CEST

See the event website https://www.esmo.org/meetings/esmo-congress-2021

ESMO Congress 2021: Programme